JOURNAL OF PRACTICAL HEPATOLOGY ›› 2015, Vol. 18 ›› Issue (6): 678-681.doi: 10.3969/j.issn.1672-5069.2015.06.031
Previous Articles Next Articles
Wang Jie, Yang Zhiguo, Wang Maorong.
Received:
2015-02-09
Online:
2015-11-20
Published:
2016-02-04
Wang Jie, Yang Zhiguo, Wang Maorong.. Role of CD8+T cells in the pathogenesis of hepatitis B virus infection[J]. JOURNAL OF PRACTICAL HEPATOLOGY, 2015, 18(6): 678-681.
[1] Honer Zu Siederdissen C,Cornberg M. The role of HBsAg levels in the current management of chronic HBV infection. Ann Gastroenterol,2014,27:105-112. [2] Thimme R,Wieland S,Steiger C,et al. CD8 + T cells mediate viral clearance and disease pathogenesis during acute hepatitis B virus infection. J Virol,2003,77(1):68-76. [3] Zhang N,Bevan MJ. CD8(+)T cells:foot soldiers of the immune system. Immunity,2011,35(2):161-168. [4] Schuch A,Hoh A,Thimme R. The role of natural killer cells and CD8 + T cells in hepatitis B virus infection. Immunology,2014,258(5):1-8. [5] Youngblood B,Hale JS,Ahmed R. T-cell memory differentiation:insights from transcriptional signatures and epigenetics. Immunology,2013,139(3):277-284. [6] Appay V,Van Lier RA,Sallusto F,et al. Phenotype and function of human T lymphocyte subsets:consensus and issues. Cytometry A,2008,73(11):975-983. [7] Shi CC,Tjwa ET,Biesta PJ,et al. Hepatitis B virus suppresses the functional interaction between natural killer cells and plasmacytoid dendritic cells. J Viral Hepat,2012,19(2):26-33. [8] Bertoletti A,Ferrari C. Innate and adaptive immune responses in chronic hepatitis B virus infections:towards restoration of immune control of viral infection. Gut,2012,61(12):1754-1764. [9] 邱洁,龙启强,冯艳红,等. 慢性乙型肝炎患者外周血NK 细胞和T 淋巴细胞计数变化及其临床意义. 实用肝脏病杂志,2010,3(13): 178-179. [10] 顾锡炳,杨小娟,王栋,等. 慢性乙型肝炎患者血清HBV DNA水平与外周血T淋巴细胞和NK细胞计数的关系. 实用肝脏病杂志,2010,6(13): 441-442. [11] Maini MK,Boni C,Lee CK,et al. The role of virus-specific CD8(+) cells in liver damage and viral control during persistent hepatitis B virus infection. J Exp Med,2000,191(8):1269-1280. [12] 吴敏娟,胥萍,王凤平. 乙型肝炎患者外周血B淋巴细胞检测的意义. 实用肝脏病杂志,2011,14(6):440-442. [13] Yang BF,Zhao HL,Xue C,et a1. Recombinant heat shock protein65 carrying hepatitis B core antigen induces HBeAg-specific CTL response. Vaccine,2007,25(22):4478-4486. [14] Sandalova E,Laccabue D,Boni C,et al. Increased levels of arginase in patients with acute hepatitis B suppress antiviral T cells. Gastroenterology,2012,143(1):78-87. [15] Phillips S,Chokshi S,Riva A,et al. CD8(+)T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions. J Immunol,2010,184(1):287-295. [16] Yan H,Zhong G,Xu G,et al. Sodium taurocholate cotrans-porting polypeptide is a functional receptor for human hepatitis B and D virus.Elife,2012,13(1):e00049. [17] Ni Y,Lempp FA,Mehrle S,et al. Hepatitis B and D viruses exploit sodium taurocholate co-transporting poly peptide for species-specific entry into hepatocytes. Gastroenterology, 2014,146(4):1070-1083. [18] Ferrari C,Penna A,Bertoletti A,et al. Cellular immune response to hepatitis B virus-encoded antigens in acute and chronic hepatitis B virus infection. J Immunol,1990,145(10):3442-3449. [19] Webster GJ,Reignat S,Brown D,et al. Lon-gitudinal analysis of CD8 + T cells specific for structural and nonstructural hepatitis B virus proteins in patients with chronic hepatitis B:implications for immunotherapy. J Virol,2004,78(11):5707-5719. [20] Lopes AR,Kellam P,Das A,et al. Bim-mediated deletion of antigen-specific CD8 T cells in patients unable to control HBV infection. J Clin Invest,2008,118(5):1835-1845. [21] van der Molen RG,Sprengers D,Binda RS,et al. Functional impairment of myeloid and plasmacytoid den-dritic cells of patients with chronic hepatitis B. Hepatology,2014,40(3):738-746. [22] Appay V,Van Lier RA,Sallusto F,et al. Phenotype and function of human T lymphocyte subsets:consensus and issues. Cytometry A,2008,73(11):975-983. [23] Boni C,Laccabue D,Lampertico P,et al. Restored function of HBV-specific T cells after long-term effective therapy with nucleos(t)ide analogues. Gastroenterology,2012,143(4):963-973. [24] Fisicaro P,Valdatta C,Massari M,et al. Antiviral intrahepatic T-cell responses can be restored by blocking programmed death-1 pathway in chronic hepatitis B. Gastroenterology, 2010,138(2):682-693. [25] Schurich A,Khanna P,Lopes AR,et al. Role of the coinhibitory receptor cytotoxic T lymphocyte antigen-4 on apoptosis-prone CD8 T cells in persistent hepatitis B virus infection. Hepatology,2011,53(5):1494-1503. [26] 陆玉蕾,王晓晶,严伟明,等. TCRγδ + CD3 + CD4 - CD8 - 双阴性T细胞在3型鼠肝炎病毒诱导的小鼠慢性病毒性肝炎发病中的作用. 实用肝脏病杂志,2012,15(4):339-342. [27] Wu W,Shi Y,Li S,et al. Blockade of Tim-3 signaling restores the virus-specific CD8(+)T-cell response in patients with chronic hepatitis B. Eur J Immunol,2012,42(5):1180-1191. [28] Raziorrouh B,Schraut W,Gerlach T,et al. The immunoregulatory role of CD244 in chronic hepatitis B infection and its inhibitory potential on virus-specific CD8 + T-cell function. Hepatology,2010,52(6):1934-1947. [29] Muhlbauer M,Fleck M,Schutz C,et al. PD-L1 is induced in hepatocytes by viral infection and by interferon-alpha and -gamma and mediates T cell apoptosis. J Hepatol,2006,45(4):520-528. [30] Knolle PA,Thimme R. Hepatic immune regulation and its involvement in viral hepatitis infection. Gastroenterology,2014,146(5):1193-1207. [31] Maier H,Isogawa M,Freeman GJ,et al. PD-1:PD-L1 interactions contribute to the functional suppression of virus-specific CD8 + T lymphocytes in the liver. J Immunol,2007,178(5):2714-2720. [32] Yang PL,Althage A,Chung J,et al. Immune effectors required for hepatitis B virus clearance. Proc Natl Acad Sci USA,2010,107(2):798-802. [33] 龚燕萍,张红星,赵超,等. IL-10 + CD 19 + 调节性B淋巴细胞在慢性乙型肝炎患者外周血中的表达.中华检验医学杂志,2014,37(2):100-104. [34] Das A,Ellis G,Pallant C,et al. IL-10-producing regulatory B cells in the pathogenesis of chronic hepatitis B virus infection. J Immunol,2012,189(8):3925-3935. [35] Das A,Hoare M,Davies N,et al. Functional skewing of the global CD8 T cell population in chronic hepatitis B virus infection. J Exp Med,2008,205(9):2111-2124. |
[1] | Chen Shuai, Yang Changqing.. Pathogenesis and risk factors of portal vein thrombosis [J]. Journal of Practical Hepatology, 2019, 22(6): 761-764. |
[2] | chronic hepatitis B Zhu Lingyun, Zhang Maohai Cui Shasha, et al.. Serum IL-12 and IL-18 levels as well as peripheral blood mononuclear cell FOXp3 in patients with [J]. Journal of Practical Hepatology, 2019, 22(6): 816-819. |
[3] | Shi Yingying, Wang Yuanxi.. Impact of combination telbivudine and adefovir dipivoxil on renal functions in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 820-823. |
[4] | Min Feng, Huang Wenqi, Wu Weibing, et al.. Implications of serum adipocytokine levels in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(6): 824-827. |
[5] | patients with chronic hepatitis B Zhang Yingming, Shen Shuang, Tian Fei, et al.. Prediction of response to peginterferon alfa-2a by blood IFNL4 and IL-28B gene polymorphisms in [J]. Journal of Practical Hepatology, 2019, 22(6): 828-831. |
[6] | chronic hepatitis B virus carriers Wu Haiyi, Chen Jianxin.. Diagnostic efficacy of four non-invasive diagnostic models in evaluating significant liver fibrosis in [J]. Journal of Practical Hepatology, 2019, 22(6): 832-835. |
[7] | Ma Liying, Shen Lijuan.. Efficacy and safety of tenofovir in the treatment of pregnant women with high HBV DNA loads [J]. Journal of Practical Hepatology, 2019, 22(6): 836-839. |
[8] | Li Chuanjie, Xu Jing, Wang Liangliang, et al.. Changes of serum HBsAg levels in patients with chronic hepatitis B receiving entecavir treatment [J]. Journal of Practical Hepatology, 2019, 22(6): 928-929. |
[9] | Liang Jubo, Miao Qi, Ma Xiong.. Diagnosis and treatment of cholangiocytic cholestasis [J]. Journal of Practical Hepatology, 2019, 22(6): 941-943. |
[10] | Du Keye, Yang Dongliang, Liu Jia. Regulatory T cells in hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 613-616. |
[11] | Liao Guichan, Peng Jie, Zhang Xiaoyong. Roles of hepatocytes in intrinsic innate immunity in control of hepatits B virus infection [J]. Journal of Practical Hepatology, 2019, 22(5): 617-619. |
[12] | Zhao Xieshan, Wu Chunrong, Wang Chunfeng, et al. Preliminary study on the efficacy of combination of tenofovir and Anluo Huaxian pill in the treatment of patients with HBeAg-negative chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 644-647. |
[13] | Tu Jiexia, Wang An’na, Liao Ruoxi. Comparative study of interferon alpha -2b and peginterferon alpha -2a in the treatment of patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 648-651. |
[14] | Gao Wei, Hou Yong. Diagnostic efficacy of hepatic fibrosis by liver stiffness measurement in patients with chronic hepatitis B [J]. Journal of Practical Hepatology, 2019, 22(5): 652-655. |
[15] | Zhu Yucheng, Yan Jiawei, Sun Jingkun, et al. Serum diamine oxidase level in patients with hepatitis B-induced acute-on-chronic liver failure [J]. Journal of Practical Hepatology, 2019, 22(5): 672-675. |
Viewed | ||||||
Full text |
|
|||||
Abstract |
|
|||||